NCT05822219View on ClinicalTrials.gov

Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 30, 2027

Conditions
Rheumatic DiseasesCOVID-19 VaccineCOVID-19SLE
Interventions
BEHAVIORAL

COVID-19 vaccine and booster training, and importance

COVID-19 vaccine and booster information training

Trial Locations (1)

60611

Northwestern University, Chicago

Sponsors

Collaborators (1)

Boston Medical Center
All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Boston Children's Hospital

OTHER

collaborator

Boston Medical Center

OTHER

lead

Northwestern University

OTHER

NCT05822219 - Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases | Biotech Hunter | Biotech Hunter